Your browser doesn't support javascript.
loading
LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression.
Jiao, Ji-Wei; Zhan, Xiu-Hui; Wang, Juan-Juan; He, Li-Xia; Guo, Zhen-Chang; Xu, Xiu-E; Liao, Lian-Di; Huang, Xin; Wen, Bing; Xu, Yi-Wei; Hu, Hai; Neufeld, Gera; Chang, Zhi-Jie; Zhang, Kai; Xu, Li-Yan; Li, En-Min.
Affiliation
  • Jiao JW; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, 515041, China.
  • Zhan XH; Department of Orthopedics, Research Center of Translational Medicine, The Second Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Wang JJ; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Shantou University Medical College, Shantou, 515041, China.
  • He LX; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Shantou University Medical College, Shantou, 515041, China.
  • Guo ZC; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, 515041, China; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, 300070, China.
  • Xu XE; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Shantou University Medical College, Shantou, 515041, China.
  • Liao LD; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, 515041, China.
  • Huang X; Department of Clinical Laboratory, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Wen B; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, 515041, China.
  • Xu YW; Department of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Hu H; Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
  • Neufeld G; Technion Integrated Cancer Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, 31096, Israel.
  • Chang ZJ; State Key Laboratory of Membrane Biology, School of Medicine, National Engineering Laboratory for Anti-tumor Therapeutics, Tsinghua University, Beijing, 10084, China.
  • Zhang K; Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, 300070, China. Electronic address: kzhang@tmu.edu.cn.
  • Xu LY; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Shantou University Medical College, Shantou, 515041, China. Electronic address: lyxu@stu.edu.cn.
  • Li EM; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, 515041, China; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute o
Redox Biol ; 57: 102496, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36209516

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Redox Biol Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Redox Biol Year: 2022 Document type: Article Affiliation country: Country of publication: